CARATOZZOLO, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 1.626
AS - Asia 1.100
EU - Europa 895
SA - Sud America 168
AF - Africa 26
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.818
Nazione #
US - Stati Uniti d'America 1.573
SG - Singapore 484
IT - Italia 307
CN - Cina 277
BR - Brasile 144
DE - Germania 141
FI - Finlandia 117
HK - Hong Kong 105
VN - Vietnam 64
FR - Francia 54
GB - Regno Unito 54
UA - Ucraina 54
RU - Federazione Russa 42
IN - India 36
TR - Turchia 32
CA - Canada 29
PL - Polonia 26
BD - Bangladesh 25
NL - Olanda 25
IE - Irlanda 24
MX - Messico 12
JP - Giappone 11
ZA - Sudafrica 10
AR - Argentina 9
PK - Pakistan 8
SE - Svezia 8
AT - Austria 7
BE - Belgio 7
SA - Arabia Saudita 7
CZ - Repubblica Ceca 6
ES - Italia 6
IQ - Iraq 6
IR - Iran 5
TW - Taiwan 5
VE - Venezuela 5
JO - Giordania 4
LT - Lituania 4
AL - Albania 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
ID - Indonesia 3
IL - Israele 3
JM - Giamaica 3
KR - Corea 3
MA - Marocco 3
NP - Nepal 3
AU - Australia 2
CI - Costa d'Avorio 2
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
KZ - Kazakistan 2
NO - Norvegia 2
PE - Perù 2
PY - Paraguay 2
UZ - Uzbekistan 2
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
GE - Georgia 1
GM - Gambi 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.818
Città #
Singapore 297
Ashburn 210
Fairfield 128
Hong Kong 105
San Jose 103
Helsinki 94
Woodbridge 65
The Dalles 64
Beijing 61
New York 60
Milan 59
Houston 58
Seattle 51
Los Angeles 50
Wilmington 50
Munich 47
Brescia 45
Cambridge 45
Jacksonville 43
Ann Arbor 40
Chandler 36
Council Bluffs 30
Lauterbourg 29
Istanbul 25
Dublin 24
Nanjing 24
Princeton 24
Warsaw 24
Dallas 23
Ho Chi Minh City 23
Turku 20
Chicago 18
Dearborn 16
São Paulo 16
Denver 15
Redondo Beach 15
Orem 14
Rome 14
Frankfurt am Main 13
Hanoi 13
San Francisco 13
Buffalo 12
Des Moines 12
Montreal 12
Moscow 12
Santa Clara 12
Mumbai 11
Shanghai 11
Nuremberg 10
Chennai 9
London 9
Jinan 8
Brussels 7
Stockholm 7
Tokyo 7
Toronto 7
Amsterdam 6
Bologna 6
Charlotte 6
Düsseldorf 6
Guangzhou 6
Naples 6
Poplar 6
Verona 6
Washington 6
Boardman 5
Brasília 5
Castelli Calepio 5
Changsha 5
Da Nang 5
Elk Grove Village 5
Hangzhou 5
Johannesburg 5
Nanchang 5
Ningbo 5
Phoenix 5
Rio de Janeiro 5
Riyadh 5
Salò 5
San Giuliano Terme 5
Taipei 5
Amman 4
Ardabil 4
Atlanta 4
Boston 4
Chapel Hill 4
João Pessoa 4
Kunming 4
Mexico City 4
Monza 4
Norwalk 4
San Diego 4
Venezia 4
Augusta 3
Baku 3
Belo Horizonte 3
Belém 3
Bolingbrook 3
Brno 3
Brooklyn 3
Totale 2.453
Nome #
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 303
COVID-19 impact on consecutive neurological patients admitted to the emergency department 252
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 235
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 216
Potentially Serious Drug-Drug Interactions in Older Patients Hospitalized for Acute Ischemic and Hemorrhagic Stroke 181
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 180
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 171
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 170
Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship? 163
Dementia after Three Months and One Year from Stroke: New Onset or Previous Cognitive Impairment? 137
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 107
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 106
Rilevazione di segnali disgrafici e grafo-patologici in un gruppo di persone affette da demenza 98
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 97
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine 96
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 96
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 94
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 93
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine 86
The impact of COVID-19 on health status of home-dwelling elderly patients with dementia in East Lombardy, Italy: results from COVIDEM network 86
Cerebral Amyloid Angiopathy in Alzheimer Disease: A Comparison between Different Versions of the Boston Criteria 84
Neurophysiological correlates of altered time awareness in Alzheimer's disease and frontotemporal dementia 84
Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison 78
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor 75
Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease 73
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study 73
The role of insulin resistance and APOE genotype on blood–brain barrier integrity in Alzheimer's disease 71
Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer’s disease and correlates with tau pathology 64
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab 61
“Real-world” eligibility for aducanumab depends on clinical setting and patients' journey 61
Photophobia and migraine outcome during treatment with galcanezumab 58
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination 57
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients 54
Totale 3.860
Categoria #
all - tutte 15.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202173 0 0 0 0 0 0 0 0 0 33 30 10
2021/2022118 6 21 1 4 1 7 10 10 11 7 12 28
2022/2023146 20 5 8 6 15 33 7 8 22 8 7 7
2023/2024178 15 3 24 9 6 39 4 7 33 4 5 29
2024/2025799 16 5 3 141 65 57 67 51 100 72 126 96
2025/20261.818 155 190 119 235 193 195 346 122 132 131 0 0
Totale 3.860